GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tenax Therapeutics Inc (FRA:YBO0) » Definitions » Float Percentage Of Total Shares Outstanding

Tenax Therapeutics (FRA:YBO0) Float Percentage Of Total Shares Outstanding : 99.64% (As of May. 28, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Tenax Therapeutics Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Tenax Therapeutics's float shares is 1.95 Mil. Tenax Therapeutics's total shares outstanding is 1.96 Mil. Tenax Therapeutics's float percentage of total shares outstanding is 99.64%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Tenax Therapeutics's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Tenax Therapeutics's Institutional Ownership is 0.10%.

Tenax Therapeutics Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Tenax Therapeutics's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=1.95/1.96
=99.64%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tenax Therapeutics (FRA:YBO0) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tenax Therapeutics Inc (FRA:YBO0) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
PULM TFFP PTIX SCPX LGVN ENTO KTTA CVKD NTBL SIGY OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB BNTX XBRU:ARGX
Traded in Other Exchanges
TENX:USA
Address
101 Glen Lennox Drive, Suite 300, Chapel Hill, NC, USA, 27517
Website
https://www.tenaxthera.com
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of Pulmonary Hypertension associated with Heart Failure and preserved Ejection Fraction.

Tenax Therapeutics (FRA:YBO0) Headlines

No Headlines